Reduced triphosphopyridine nucleotide oxidase-catalyzed alterations of membrane phospholipids. II. Enzymic properties and stoichiometry.
D000447:Aldehydes / Q000378:metabolism; D000818:Animals; D001565:Benzoates / Q000494:pharmacology; D003035:Cobalt / Q000494:pharmacology; D003080:Cold Temperature; D005227:Fatty Acids / Q000378:metabolism; D006358:Hot Temperature; D066298:In Vitro Techniques; D008297:Male; D008314:Malonates / Q000378:metabolism; D008628:Mercury / Q000494:pharmacology; D009249:NADP / Q000378:metabolism*; D010088:Oxidoreductases / Q000037:antagonists & inhibitors / Q000378:metabolism*; D010101:Oxygen Consumption; D010743:Phospholipids / Q000378:metabolism*; D051381:Rats; D012663:Semicarbazides / Q000494:pharmacology; D014810:Vitamin E / Q000494:pharmacology
D000447:Aldehydes; D001565:Benzoates; D005227:Fatty Acids; D008314:Malonates; D010743:Phospholipids; D012663:Semicarbazides; D014810:Vitamin E; D003035:Cobalt; D009249:NADP; D010088:Oxidoreductases; D008628:Mercury